当前位置:首页 - 行情中心 - 和邦生物(603077) - 财务分析 - 现金流量表

和邦生物

(603077)

  

流通市值:198.71亿  总市值:198.71亿
流通股本:88.32亿   总股本:88.32亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金2,183,959,713.871,101,227,572.596,427,623,560.584,616,047,432.45
  收到的税费返还147,169,671.7420,445,349.14113,708,087.0988,609,118.78
  收到其他与经营活动有关的现金49,548,481.4725,783,283.97115,259,286.0589,805,300.72
  经营活动现金流入小计2,380,677,867.081,147,456,205.76,656,590,933.724,794,461,851.95
  购买商品、接受劳务支付的现金1,649,634,114.48872,209,683.354,303,989,899.483,516,002,254
  支付给职工以及为职工支付的现金303,521,693.07170,823,845.22635,026,864485,630,532.41
  支付的各项税费172,010,810.2849,205,694.34489,486,461.8356,560,413.58
  支付其他与经营活动有关的现金66,430,761.2932,603,069.8151,851,097.29126,132,124.58
  经营活动现金流出小计2,191,597,379.121,124,842,292.715,580,354,322.574,484,325,324.57
  经营活动产生的现金流量净额189,080,487.9622,613,912.991,076,236,611.15310,136,527.38
二、投资活动产生的现金流量:
  收回投资收到的现金--77,052,422.3977,052,422.39
  取得投资收益收到的现金9,777,640.631,120,0001,853,787.831,853,787.83
  处置固定资产、无形资产和其他长期资产收回的现金净额251,347.65237,694.76992,672.44942,906.36
  收到的其他与投资活动有关的现金19,487,374.959,934,778.52115,464,579.2551,824,133.01
  投资活动现金流入小计29,516,363.2311,292,473.28195,363,461.91131,673,249.59
  购建固定资产、无形资产和其他长期资产支付的现金657,246,389.95253,023,190.11,258,913,532.7670,592,812.65
  投资支付的现金--97,698,304.4297,066,904.99
  支付其他与投资活动有关的现金1,330,0001,330,000187,315,553.71147,724,970.34
  投资活动现金流出小计658,576,389.95254,353,190.11,543,927,390.83915,384,687.98
  投资活动产生的现金流量净额-629,060,026.72-243,060,716.82-1,348,563,928.92-783,711,438.39
三、筹资活动产生的现金流量:
  吸收投资收到的现金--120,000120,000
  其中:子公司吸收少数股东投资收到的现金--120,000120,000
  取得借款收到的现金2,017,800,0001,501,600,0003,900,876,713.763,443,576,713.76
  收到其他与筹资活动有关的现金1,056,002,317.8372,885,716.1273,931,506.5774,061,458.45
  筹资活动现金流入小计3,073,802,317.831,574,485,716.123,974,928,220.333,517,758,172.21
  偿还债务支付的现金1,961,676,197.041,170,516,373.723,367,733,749.292,654,844,534.45
  分配股利、利润或偿付利息支付的现金63,545,682.4831,713,434.26135,774,305.3391,599,219.32
  其中:子公司支付给少数股东的股利、利润--22,632.7422,632.74
  支付其他与筹资活动有关的现金7,574,830.322,993,932.71327,996,857.27323,420,197.1
  筹资活动现金流出小计2,032,796,709.841,205,223,740.693,831,504,911.893,069,863,950.87
  筹资活动产生的现金流量净额1,041,005,607.99369,261,975.43143,423,308.44447,894,221.34
四、汇率变动对现金及现金等价物的影响-51,286,958.09-24,821,057.89-38,462,235.45-21,786,823.99
五、现金及现金等价物净增加额549,739,111.14123,994,113.71-167,366,244.78-47,467,513.66
  加:期初现金及现金等价物余额6,684,196,816.016,681,673,478.826,851,563,060.796,851,563,060.79
  期末现金及现金等价物余额7,233,935,927.156,805,667,592.536,684,196,816.016,804,095,547.13
补充资料:
  净利润374,581,964.58--712,664,631.51-
  资产减值准备39,700,767.03-763,172,731.83-
  固定资产和投资性房地产折旧433,371,291.69-930,216,134.69-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧433,371,291.69-930,216,134.69-
  无形资产摊销21,782,249.19-66,863,984.74-
  长期待摊费用摊销196,226.4-392,452.8-
  处置固定资产、无形资产和其他长期资产的损失-7,434.41-4,361,435.6-
  固定资产报废损失12,323.56-13,504,372.43-
  财务费用93,124,283.72-143,505,434.15-
  投资损失-6,847,995.08-5,005,111.27-
  递延所得税18,249,833.02--35,615,185.21-
  其中:递延所得税资产减少8,253,350.36--23,269,744.9-
    递延所得税负债增加9,996,482.66--12,345,440.31-
  存货的减少-435,662,321.97-304,245,999.79-
  经营性应收项目的减少-277,616,222.8-540,438,280.37-
  经营性应付项目的增加-95,999,229.49--990,581,733.63-
  其他5,541,392.07-15,913,023.62-
  现金的期末余额7,233,935,927.15-6,684,196,816.01-
  减:现金的期初余额6,684,196,816.01-6,851,563,060.79-
  现金及现金等价物的净增加额549,739,111.14--167,366,244.78-
公告日期2026-08-182026-04-212026-04-212025-10-29
审计意见(境内)标准无保留意见
TOP↑